Zobrazeno 1 - 10
of 47
pro vyhledávání: '"M, Elmlinger"'
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 47:236-245
Objective: To investigate the effects of steady state erythromycin on the pharmacokinetics of roflumilast and its pharmacodynamically active metabolite roflumilast N-oxide in healthy subjects. Both roflumilast and roflumilast N-oxide have similar int
Publikováno v:
Acta Paediatrica. 88:62-65
In Duchenne muscular dystrophy (DMD), short stature is a feature of unknown cause. This cross-sectional study of 34 male patients (mean age 8.0 y, age range 1.2-13.7 y) was conducted to examine the relationship between auxological parameters, markers
Autor:
M. B. Ranke, M. Elmlinger, G. E. Dannecker, J. Berger, S. Hettmer, L. Dannecker, D. Niethammer, J. L. Föll, C. Zehrer
Publikováno v:
Immunology. 94:173-180
The expression of the insulin-like growth factor binding protein-2 (IGFBP-2) was assayed in mononuclear cells originating from different organs of the immune system. All mononuclear cells studied did express IGFBP-2, but the expression level was foun
Autor:
MF Beers, Jens M. Hohlfeld, VJ Erpenbeck, EA Atochina-Vassermann, M Elmlinger, Norbert Krug, Carla Winkler
Publikováno v:
D106. SURFACTANT AND COLLECTINS STRUCTURE AND FUNCTION: INSIGHTS INTO DISEASE MECHANISMS.
Autor:
B. Hauns, H. Heinzerling, G. Grentzmann, R. Beume, S. Sanjar, K. Melchers, M. Elmlinger, K. Schoenfeld, S. L. Wollin, R. Hermann, C. Hesslinger
Publikováno v:
Pneumologie. 60
Publikováno v:
Clinical endocrinology. 51(1)
A GH deficiency-like phenotype with normal or high hGH secretion, pathologically low IGF-I serum levels, and catch-up growth under treatment with recombinant hGH is suggestive of the presence of biologically inactive hGH syndrome, whose presumably he
Publikováno v:
Acta paediatrica (Oslo, Norway : 1992). 88(1)
In Duchenne muscular dystrophy (DMD), short stature is a feature of unknown cause. This cross-sectional study of 34 male patients (mean age 8.0 y, age range 1.2-13.7 y) was conducted to examine the relationship between auxological parameters, markers
Publikováno v:
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. 5
Pharmacokinetics of subcutaneously administered recombinant growth hormone (rGH) were studied in nine GH deficient children at the time of the first rGH injection at the beginning of treatment. Serum GH levels were determined by four different method
Autor:
B. Adinolfi, E. Milgrom, I. Beau, R.E. Reddingius, B. Vannier, C. Capuano, G. Vassart, J. Timsit, A. Colao, A. Balestrieri, B.M. Brennan, S. Longobardi, G. Lombardi, N. Caballo, C. Terzi, D. Ferone, V. Barriosa, M. Rosilio, S. Mariotti, W.F. Blum, H. Loosfelt, M. Hernández, M. Songint, J.F. Savouret, A. Loviselli, F. Orio, M. Vanelli, Bo Carlsson, A. Attanasio, N. Ghinea, S.M. Shalet, J. Argente, B. Merola, C.L. Boguszewski, R. Cirillo, V.K. Ramiya, G. Chiari, D. Blazy, E. Larger, J. Pozo, J.-C. Carel, M.B. Ranke, M.E. Street, L.M.S. Carlsson, N.K. Maclaren, M. Misrahi, V.K.K. Chatterjee, C. Boitard, P. Froguel, J.A. Chowen, M.T. Muñoz, F. Velluzzi, G.F. Bottazzo, V. Sepe, A.P. Weetman, G. Delitala, D. Dubois, P. Nizzia, M. Elmlinger, N. de Roux, J.L. Chaussain, P. Marzullo, E. Cossu
Publikováno v:
Hormone Research in Paediatrics. 54:75-75
Publikováno v:
Immunology Letters. 56:89